1-7 of 7
Martin Lackmann, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immunotherapeutic Targeting of EphA3

Sara Charmsaz, Kirrilee J Miller, Bryan W Day, PhD, Fares El-Ajeh, PhD, Varghese Palath, PhD, Geoff T Yarranton, PhD, Christopher R Bebbington, DPhil., Andrew M Scott, PhD, Martin Lackmann, PhD, Andrew W Boyd, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3720.
https://doi.org/10.1182/blood.V124.21.3720.3720
Published: 2014
Journal Articles

EphA3 As a Target For Monoclonal Antibody Therapy For Acute Leukemia

Sara Charmsaz, Kirrilee J Miller, Bryan W Day, PhD, Fares El-Ajeh, PhD, Geoff T Yarranton, PhD, Christopher R Bebbington, DPhil., Andrew M Scott, PhD, Martin Lackmann, PhD, Andrew W Boyd, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5013.
https://doi.org/10.1182/blood.V122.21.5013.5013
Published: 2013
Journal Articles

EphA3 As a Molecular Target In Multiple Myeloma: Opportunity For a Novel Therapeutic Approach With a Specific Monoclonal Antibody

Antonella Caivano, Francesco La Rocca, Ilaria Laurenzana, Alessandra Favole, PhD, Irma Airoldi, PhD, Emma Di Carlo, MD, PhD, Valentina Gaidano, Enrico Bracco, PhD, Oreste Villani, Giuseppe Pietrantuono, Luciana De Luca, Annalisa Morano, Vittorio Simeon, Stefania Trino, Simona Berardi, Antonio Basile, Martin Lackmann, PhD, Angelo Vacca, MD, PhD, Pellegrino Musto, MD, Francesco Frassoni, Daniela Cilloni
Journal: Blood
Blood (2013) 122 (21): 3211.
https://doi.org/10.1182/blood.V122.21.3211.3211
Published: 2013
Journal Articles

A Recombinant Antibody to EphA3 for the Treatment of Hematologic Malignancies: Research Update and Interim Phase 1 Study Results

Anne Hagey, M.D., Jeffrey E. Lancet, MD, Varghese Palath, PhD, Andrew H Wei, MBBS, PhD, Martin Lackmann, PhD, Jorge E. Cortes, Andrew Boyd, MD, PhD, Dan Shochat, PhD, Geoffrey Yarranton, PhD, Christopher Bebbington, DPhil., Jonathan A. Leff, MD
Journal: Blood
Blood (2011) 118 (21): 4893.
https://doi.org/10.1182/blood.V118.21.4893.4893
Published: 2011
Journal Articles

A Recombinant Antibody to EphA3 with Pro-Apoptotic and Enhanced ADCC Activity Against Various Hematologic Malignancies Shows Selective Inhibition of Colony Formation From Long-Term Culture-Initiating Cells (LTC-ICs) In Primary Leukemia Samples

Varghese Palath, PhD, Rohini Vekhande, Mark Baer, PhD, Wendy Ching, PhD, Nenad Tomasevic, PhD, David Martinez, Christina Yi, Swathi Bhaskar, Kenneth Luehrsen, Jason Williams, John Leung, Alan F. List, MD, Ling Zhang, MD, Martin Lackmann, PhD, Andrew Boyd, MD, PhD, Andrew Scott, PhD, Daniela Cilloni, MD, PhD, Geoffrey Yarranton, PhD, Christopher Bebbington, DPhil.
Journal: Blood
Blood (2010) 116 (21): 2897.
https://doi.org/10.1182/blood.V116.21.2897.2897
Published: 2010
Journal Articles

A Recombinant Human Antibody to EphA3 with Pro-Apoptotic and Enhanced ADCC Activity Shows Selective Cytotoxicity against Myeloid Leukemia Cells and CD123-Positive Leukemic Stem Cells.

Varghese Palath, PhD, Rohini Vekhande, Andreia Lee, Jason Williams, Ling Zhang, MD, Alan F List, MD, Andrew Boyd, MD, PhD, Martin Lackmann, PhD, Andrew M Scott, PhD, Daniela Cilloni, MD, PhD, Geoffrey T. Yarranton, PhD, Christopher Bebbington, DPhil
Journal: Blood
Blood (2009) 114 (22): 1728.
https://doi.org/10.1182/blood.V114.22.1728.1728
Published: 2009
Journal Articles

EphA3 Kinase Is Constitutively Activated in Chronic Myeloid Leukaemia during Progression to Accelerated and Blast Crisis and It Could Represent a New Molecular Target.

Daniela Cilloni, MD, PhD, Francesca Arruga, PhD, Sonia Carturan, PhD, Francesca Messa, PhD, Monica Pradotto, PhD, Ilaria Defilippi, PhD, Marisa Pautasso, MD, Ilaria Iacobucci, PhD, Giovanni Martinelli, MD, Enrico Bracco, PhD, Thea Kalebic, MD, Martin Lackmann, PhD, Giuseppe Saglio, MD
Journal: Blood
Blood (2008) 112 (11): 1092.
https://doi.org/10.1182/blood.V112.11.1092.1092
Published: 2008